CHEK2 and breast carcinoma: The probability of breast cancer diagnosis at age 70 in individuals with a pathogenic variant in ATM of CHEK2 and in the top 50% of the PRS distribution was 39.2%, whereas those in the bottom 50% of the PRS distribution had a risk of only 14.4% (Figure 3C, Supplemental Table 10).